Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-14-041738
Filing Date
2014-06-16
Accepted
2014-06-16 20:00:20
Documents
1
Period of Report
2014-06-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3944
  Complete submission text file 0001209191-14-041738.txt   5318
Mailing Address 428 UNIVERSITY AVE C/O ACCEL PARTNERS PALO ALTO CA 94301
Business Address
KLINGENSTEIN PAUL H (Reporting) CIK: 0000935463 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35347 | Film No.: 14924018

Mailing Address 2525 28TH STREET SUITE 100 BOULDER CO 80301
Business Address 2525 28TH STREET SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Issuer) CIK: 0001466301 (see all company filings)

EIN.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations